Search

everythinglearnresearchcommunity

for

Search:↓

Apremilast did not work for treating severe alopecia areata.

Congenital atrichia is a rare condition where children are born without hair, and treatment is often ineffective.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

A COVID-19 patient with severe hair loss did not improve with hair loss medication after stopping and restarting it due to the infection.

Tofacitinib significantly regrows hair in severe alopecia without major side effects.

The study found that a specific type of hair loss is increasingly common in premenopausal women and can be effectively diagnosed and treated with various medications.

Tofacitinib may effectively treat folliculitis decalvans.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.

Inorganic nanomaterials can improve brain disease imaging by being more precise and faster than traditional methods.

Early treatment and multidisciplinary care are key to managing Frontal Fibrosing Alopecia and preventing further hair loss.

Hair loss in both Androgenetic Alopecia and Alopecia Areata is often accompanied by inflammation around hair follicles, but the location and severity of this inflammation varies.

Dermoscopy shows that diffuse alopecia areata progresses through specific hair growth stages.

Tofacitinib effectively reduces hair loss in children with alopecia areata but may cause mild side effects and relapses.

Using facial sunscreen and moisturizer may increase the risk of frontal fibrosing alopecia.

Combining excimer lamp and tofacitinib gel may help treat hair loss in children.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

A male patient developed frontal fibrosing alopecia after antiandrogen therapy for prostate cancer.

The FDA approved a new Pfizer drug for hair loss in teens.

Antifungal treatment reduced asthma exacerbations and corticosteroid use but its overall benefit is unclear.

Filaggrin mutations are linked to atopic dermatitis and help explain how genetics and environment affect the disease.

Machine learning can use blood tests to help predict moderate-to-severe alopecia areata.

Transdermal delivery using a fractional CO2 laser is more effective for treating alopecia areata than injections.

The TPAP method effectively categorizes androgenetic alopecia patients with high accuracy, but needs real-world validation.

A specific ATR gene mutation is linked to a hereditary oropharyngeal cancer syndrome.

TAF can be identified by excessive skin thickening and clogged hair follicles, helping distinguish it from similar skin conditions.

Intralesional triamcinolone acetonide helps regrow eyebrows in patients with frontal fibrosing alopecia.

Tofacitinib effectively treated severe alopecia areata in a 14-year-old girl.

A woman got a skin rash from taking aceclofenac, which went away after she stopped the drug.

Aminexil clinical 5 effectively reduces hair loss and is well-tolerated.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.